跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 126 条关于
“mastocytosis”
全部
126
临床试验
89
药物
4
机构
0
资讯
33
4个月前
NICE Recommends Blueprint Medicines' Ayvakyt for Advanced Systemic Mastocytosis on NHS
去年
Bezuclastinib Shows Strong Symptom and Biomarker Improvement in Non-Advanced Systemic Mastocytosis
去年
Avapritinib Shows Promising Improvements in Bone Density for Advanced Systemic Mastocytosis Patients
10个月前
Cogent Biosciences Raises $475.3 Million to Advance Bezuclastinib for Systemic Mastocytosis
去年
Bezuclastinib Achieves 87% Response Rate in Pivotal Trial for Non-Advanced Systemic Mastocytosis
去年
Avapritinib Shows Durable Long-Term Response in Indolent Systemic Mastocytosis as Pipeline Expands
9个月前
Blueprint Medicines Reports Long-Term Efficacy Data for AYVAKIT in Systemic Mastocytosis at ASH 2025
4个月前
Ayvakit (Avapritinib): High Response Rates in Rare Cancers and Mastocytosis, With Critical Safety Monitoring Requirements
前天
FDA Accepts Cogent Biosciences' NDA for Bezuclastinib in Advanced Systemic Mastocytosis, PDUFA Set for June 2027
11个月前
Swissmedic Approves Two Orphan Drugs for Rare Cancers: Ayvakyt for GIST and Mastocytosis, VANFLYTA for FLT3-ITD AML
第 1 页,共 4 页
上一页
下一页